Human brucellosis is considered to be an important but typically under-diagnosed cause of febrile illness in many low and middle-income countries. In Kenya, and throughout East Africa, laboratory diagnosis for the disease is based primarily on the febrile antigen Brucella agglutination test (FBAT), yet few studies of the diagnostic accuracy of this test exist. Assessment of the performance of the FBAT is essential for its appropriate clinical use, as well as for evaluating surveillance data reported by public health systems. To assess FBAT performance, we collected sera from people with symptoms compatible with brucellosis attending 2 health facilities in Busia County, Kenya
This work arises from the Zoonoses and Emerging Livestock Systems (ZELS) programme.
de Glanville W, Conde-Álvarez R, Moriyón I, Njeru J, Díaz R, Cook E, Morin M, Bronsvoort B, Thomas L, Kariuki S, Fèvre E (2017). Poor performance of the rapid test for human brucellosis in health facilities in Kenya. PLoS Negl Trop Dis. 11(4): e0005508
Poor performance of the rapid test for human brucellosis in health facilities in Kenya